NAFDAC warns of counterfeit Dostinex tablets in Nigeria
ArchivedVerified|2 articles|2 sources|1 blocks
Detected: Updated: Analyzed:
Reported Facts
Observable data points shared across all narratives
- •NAFDAC identified falsified and unregistered batches of Dostinex tablets in circulation.
- •Dostinex is a medication used to treat certain medical conditions, including hormonal disorders.
- •The warning was issued in Nigeria on February 23, 2026.
- •NAFDAC urged consumers and healthcare providers to verify the authenticity of Dostinex before use.
What Could Happen If...
- ▸If NAFDAC successfully removes counterfeit Dostinex from the market patients in Nigeria will have safer access to genuine medication, reducing health risks associated with fake drugs.
Key Actors
Countries
Instruments
Source Coverage
AFRICA
2 articles
More coverage on this story
- More on Nigeria
- More on Dostinex
- More on National Agency for Food and Drug Administration and Control
Signals
Single-block coverage
Related Events
▸NAFDAC warns of counterfeit breast cancer drug Phesgo in NigeriaArchived▸NAFDAC seizes banned cosmetics worth N3 billion in Lagos warehouseArchived▸NAFDAC recalls male enhancement capsules over safety concernsArchived▸NAFDAC seals 18 warehouses for expired food products in Niger State, NigeriaArchived▸Nigeria Health Ministry Says NAFDAC Enforces Sachet Alcohol Ban